|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-8-27
|
|
pubmed:abstractText |
Drug-eluting stents are now used in most percutaneous coronary interventions. There are only 2 approved devices: sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Only a few population-based studies have compared their patient outcomes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
154
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
545-53
|
|
pubmed:meshHeading |
pubmed-meshheading:17719304-Aged,
pubmed-meshheading:17719304-Aged, 80 and over,
pubmed-meshheading:17719304-Coronary Vessels,
pubmed-meshheading:17719304-Drug Delivery Systems,
pubmed-meshheading:17719304-Female,
pubmed-meshheading:17719304-Humans,
pubmed-meshheading:17719304-Male,
pubmed-meshheading:17719304-Middle Aged,
pubmed-meshheading:17719304-Myocardial Infarction,
pubmed-meshheading:17719304-Myocardial Revascularization,
pubmed-meshheading:17719304-Paclitaxel,
pubmed-meshheading:17719304-Sirolimus,
pubmed-meshheading:17719304-Stents
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents.
|
|
pubmed:affiliation |
School of Public Health, University at Albany, State University of New York, Albany, NY 12144-3456, USA. elh03@health.state.ny.us
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
